| Product NDC: | 47781-205 |
| Proprietary Name: | Estradiol Transdermal System |
| Non Proprietary Name: | Estradiol |
| Active Ingredient(s): | .0375 mg/d & nbsp; Estradiol |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 47781-205 |
| Labeler Name: | Alvogen, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020375 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20111220 |
| Package NDC: | 47781-205-04 |
| Package Description: | 4 PATCH in 1 CARTON (47781-205-04) > 7 d in 1 PATCH |
| NDC Code | 47781-205-04 |
| Proprietary Name | Estradiol Transdermal System |
| Package Description | 4 PATCH in 1 CARTON (47781-205-04) > 7 d in 1 PATCH |
| Product NDC | 47781-205 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Estradiol |
| Dosage Form Name | PATCH |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 20111220 |
| Marketing Category Name | NDA |
| Labeler Name | Alvogen, Inc. |
| Substance Name | ESTRADIOL |
| Strength Number | .0375 |
| Strength Unit | mg/d |
| Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |